<DOC>
	<DOCNO>NCT00397631</DOCNO>
	<brief_summary>A clinical study evaluate safety efficacy initial combination therapy sitagliptin pioglitazone patient type 2 diabetes mellitus treatment insulin oral antihyperglycemic therapy .</brief_summary>
	<brief_title>Initial Combination With Pioglitazone Study ( 0431-064 )</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Pioglitazone</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>General Patients â‰¥18 year old Type 2 Diabetes Mellitus ( specific type diabetes ) General Patient history type 1 diabetes mellitus history ketoacidosis Patient antihyperglycemic agent therapy ( oral insulin ) within prior 4 month Patient &gt; 4 week ( cumulatively ) antihyperglycemic therapy ( oral insulin ) prior 2 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>